Spinal tap test could predict lung Cancer's spread to brain
NCT ID NCT06816979
Summary
This study aims to see if a spinal fluid test can predict which patients with advanced lung cancer are likely to develop brain metastases. Researchers will collect spinal fluid and blood from 40 patients with stage III or IV non-small cell lung cancer, some with and some without existing brain spread. The goal is to determine if tumor DNA found in the spinal fluid can reliably predict future brain metastases, which could lead to better monitoring and earlier intervention.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NON-SMALL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.